130 related articles for article (PubMed ID: 1664295)
1. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
Su W
Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.
Agarwal A; Sharma D; Kumari S; Khare S
Indian Pediatr; 1991 Oct; 28(10):1141-5. PubMed ID: 1665840
[TBL] [Abstract][Full Text] [Related]
3. [A study on immunization of polio vaccine. II. Comparison of responses obtained by different forms of polio vaccine].
Su W
Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):284-5. PubMed ID: 1664296
[TBL] [Abstract][Full Text] [Related]
4. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
Samoilovich E; Roivainen M; Titov LP; Hovi T
J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of enhanced potency inactivated polio vaccine.
Singh J; Ravi RN; Dutta AK; Kumari S; Khare S
Indian Pediatr; 1992 Nov; 29(11):1353-6. PubMed ID: 1338200
[TBL] [Abstract][Full Text] [Related]
6. Early immunization of neonates with trivalent oral poliovirus vaccine.
Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
[TBL] [Abstract][Full Text] [Related]
7. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
8. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
[TBL] [Abstract][Full Text] [Related]
9. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
[TBL] [Abstract][Full Text] [Related]
10. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
[TBL] [Abstract][Full Text] [Related]
11. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
12. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
14. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
Cáceres VM; Sutter RW
Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
[TBL] [Abstract][Full Text] [Related]
15. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
[TBL] [Abstract][Full Text] [Related]
16. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
[TBL] [Abstract][Full Text] [Related]
17. Use of a combined DTP-polio vaccine in a reduced schedule.
Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N
Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820
[TBL] [Abstract][Full Text] [Related]
18. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
19. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria.
Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M
J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311
[TBL] [Abstract][Full Text] [Related]
20. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
Kong J
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
